Joint Filing AgreementJoint Filing Agreement • February 6th, 2023 • Biotechnology Value Fund L P • Investment advice
Contract Type FiledFebruary 6th, 2023 Company IndustryThe undersigned hereby agree that the Statement on Schedule 13G dated February 6, 2023 with respect to the Voting Common Stock, par value $0.0001 per share, of Jasper Therapeutics, Inc., a Delaware corporation, and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.